BofA warns Fed risks policy mistake with early rate cuts
Investing.com - Berenberg has lowered its price target on Carl Zeiss Meditec AG (ETR:AFX) (OTC:CZMWY) to €47.00 from €65.00 while maintaining a Hold rating on the stock.
The price target reduction comes as Carl Zeiss Meditec has faced multiple challenges in its post-pandemic recovery, including weak consumer confidence and volume-based procurement issues in China.
The medical technology company has also been impacted by high interest rates affecting capital equipment spending in the United States, contributing to an approximately 80% decline in its share price since 2021 highs.
Berenberg analyst Beatrice Allen cited the company’s exposure to China as a key concern, specifically noting "low visibility on refractive surgical procedures and a lack of reliable market data" in that market.
The firm’s continued Hold rating reflects these ongoing challenges, with China recovery dynamics remaining a significant barrier to a more positive outlook on the stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.